|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.04.26 - 07:03
|
Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency (Business Wire)
|
|
|
Ad hoc announcement pursuant to Art. 53 LRZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026.
Strong start to the year delivering net sales of 1,473 million USD, predominantly driven by volume and complemented by positive price and mix effects, underscoring the continued execution of its unique, growth-driven integrated dermatology strategy.
Widespread net sales growth of 25.5% year-on-year at constant currency1, aligned with strong growth performance across geographies and product categories, including Injectable Aesthetics (+13.1%), Dermatological Skincare (+17.0%) and Therapeutic Dermatology (+71.3%).
Continued market outperformance, with broad-based growth momentum across the existing portfolio, complemented by differentiated launches and geographic expansion.
Demonstrated scientific leadership with new clinical data presented at major congresses, including positive phase II res...
|
|
|
22.04.26 - 17:48
|
Galderma Shareholders Approve All Annual General Meeting Proposals (Business Wire)
|
|
|
ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, announced that shareholders approved all proposals put forward by the Board of Directors at its Annual General Meeting (AGM), held earlier today via live webcast. This includes the payment of a gross dividend of 0.35 CHF per dividend-bearing share1, to be distributed out of reserves from capital contributions.
Shareholders approved the election of Harry Kirsch as independent member of the Board of Directors, as well as the election of Samuel du Retail and Delphine Viguier-Hovasse, representatives of L'Oréal, as non-independent members of the Board. In addition, Thomas Ebeling (Chair), Daniel Browne, Maria Teresa Hilado, Karen Lee Ling, Roberto Marques, Sherilyn McCoy and Dr. Flemming Ørnskov were re-elected to the Board.
The AGM also approved the company's 2025 Annual Financial Statements, Non-Financial Report and Compensation Report.
Detailed voting results and the official minutes will be publ...
|
|
|
|
|
|
|
22.04.26 - 07:01
|
EQT AB (publ) Q1 Annoucement 2026 (Cision)
|
|
|
Continued strong execution in a volatile market environment
“EQT executed well in a quarter where the market environment was characterized by AI-driven volatility and geopolitical uncertainty. We remained disciplined in selectively pursuing thematic investments, the vast majority of those invested into the AI opportunity. We continued to drive monetizations, highlighted by the $6 billion sale of our remaining public stake in Galderma - the most successful private equity investment ever in terms of capital gain from a single fund. Delivering strong returns at scale is a testament to EQT's...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
